REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383 | +25.6% | 23,305 | +52.6% | 0.00% | – |
| Q2 2023 | $305 | +498.0% | 15,272 | +466.0% | 0.00% | – |
| Q1 2023 | $51 | +325.0% | 2,698 | +393.2% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 547 | -53.9% | 0.00% | – |
| Q3 2022 | $31,000 | +210.0% | 1,186 | +267.2% | 0.00% | – |
| Q1 2022 | $10,000 | +900.0% | 323 | +941.9% | 0.00% | – |
| Q4 2021 | $1,000 | -92.3% | 31 | -91.9% | 0.00% | – |
| Q1 2021 | $13,000 | -99.4% | 385 | -99.2% | 0.00% | -100.0% |
| Q4 2020 | $2,115,000 | +13118.8% | 46,632 | +7724.2% | 0.00% | – |
| Q3 2020 | $16,000 | -96.4% | 596 | -95.1% | 0.00% | -100.0% |
| Q2 2020 | $447,000 | +1.8% | 12,150 | -10.4% | 0.00% | 0.0% |
| Q1 2020 | $439,000 | -0.7% | 13,565 | +25.7% | 0.00% | 0.0% |
| Q4 2019 | $442,000 | +3918.2% | 10,791 | +3189.9% | 0.00% | – |
| Q3 2019 | $11,000 | -85.5% | 328 | -77.9% | 0.00% | – |
| Q2 2019 | $76,000 | -39.7% | 1,484 | -65.1% | 0.00% | -100.0% |
| Q1 2018 | $126,000 | -48.6% | 4,252 | -42.4% | 0.01% | -45.5% |
| Q4 2017 | $245,000 | – | 7,377 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |